Though historically cancer was viewed as a tissue-based maladaptive response compounded by inflammation [33], the majority of recent literature has been focused on key molecular players such as TGFβ [34], VEGF [35], and matrix metalloproteinases (MMPs) [36]. The gene discussed is VEGFA; the disease is cancer.